Simultaneous quantitative detection of afatinib, erlotinib, gefitinib, icotinib, osimertinib and their metabolites in plasma samples of patients with non-small cell lung cancer using liquid chromatography-tandem mass spectrometry
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Simultaneous quantitative detection of afatinib, erlotinib, gefitinib, icotinib, osimertinib and their metabolites in plasma samples of patients with non-small cell lung cancer using liquid chromatography-tandem mass spectrometry
Authors
Keywords
LC–MS/MS, Therapeutic drug monitoring, EGFR-TKIs, Metabolites, Non-small cell Lung cancer
Journal
CLINICA CHIMICA ACTA
Volume 527, Issue -, Pages 1-10
Publisher
Elsevier BV
Online
2022-01-06
DOI
10.1016/j.cca.2021.12.028
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantification of afatinib, alectinib, crizotinib and osimertinib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry; focusing on the stability of osimertinib
- (2019) G.D. Marijn Veerman et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Therapeutic drug monitoring of oral anticancer drugs
- (2019) Stefanie L. Groenland et al. THERAPEUTIC DRUG MONITORING
- Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
- (2019) Suresh S. Ramalingam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simultaneous quantitative determination of seven novel tyrosine kinase inhibitors in plasma by a validated UPLC-MS/MS method and its application to human microsomal metabolic stability study
- (2019) Essam Ezzeldin et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Bioanalysis of EGFRm inhibitor osimertinib, and its glutathione cycle- and desmethyl metabolites by liquid chromatography-tandem mass spectrometry
- (2019) J.J.M. Rood et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer
- (2019) Keiko Nakao et al. Scientific Reports
- Validation of an LC-MS/MS method for simultaneous determination of icotinib and its four major circulating metabolites in human plasma and its application in a pharmacokinetic study
- (2018) Ying Xiao et al. BIOMEDICAL CHROMATOGRAPHY
- Optimizing outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when?
- (2018) Nicolas Girard Future Oncology
- Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients
- (2018) Rafael Reis et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Liquid chromatography–tandem mass spectrometric assay for the T790M mutant EGFR inhibitor osimertinib (AZD9291) in human plasma
- (2016) Johannes J.M. Rood et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Liquid chromatographytandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O desmethyl metabolites of erlotinib and gefitinib in human plasma
- (2016) Rolf W. Sparidans et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Chromatographic behavior of 12 polar pteridines in hydrophilic interaction chromatography using five different HILIC columns coupled with tandem mass spectrometry
- (2016) Xin Xiong et al. TALANTA
- Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer
- (2015) Hideki Hayashi et al. BIOMEDICAL CHROMATOGRAPHY
- Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non-small cell lung cancer
- (2015) Jun Ni et al. CANCER
- A validated liquid chromatography tandem mass spectrometry method for quantification of erlotinib, OSI-420 and didesmethyl erlotinib and semi-quantification of erlotinib metabolites in human plasma
- (2015) Anna Svedberg et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Therapeutic Effects and Adverse Drug Reactions are Affected by Icotinib Exposure and CYP2C19 and EGFR Genotypes in Chinese Non-Small Cell Lung Cancer Patients
- (2014) Jia Chen et al. Asian Pacific Journal of Cancer Prevention
- Simultaneous determination of erlotinib and its isomeric major metabolites in human plasma using isocratic liquid chromatography-tandem mass spectrometry and its clinical application
- (2014) Takuya Ishida et al. BIOMEDICAL CHROMATOGRAPHY
- Drug–drug interactions with tyrosine-kinase inhibitors: a clinical perspective
- (2014) Roelof W F van Leeuwen et al. LANCET ONCOLOGY
- Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients
- (2014) J.L. Kuiper et al. LUNG CANCER
- Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer
- (2013) Masahide Fukudo et al. CLINICAL PHARMACOKINETICS
- The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib
- (2010) Yuan-Yuan Zhao et al. MEDICAL ONCOLOGY
- Quantitative determination of icotinib in human plasma and urine using liquid chromatography coupled to tandem mass spectrometry
- (2009) Dongyang Liu et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search